LCD L35026: Rituximab — Palmetto GBA
Oncology
Government source· CMS / MACverify ↗HCPCS Level II code
J9311 — Injection, rituximab 10 mg and hyaluronidase
HCPCS Level IIVerified Sep 19, 2026
Medicare payment
—
No national Medicare fee schedule we hold prices J9311 — the Physician Fee Schedule lists it with status indicator E (2026 file). CMS fee schedules ↗
Code definition
Code
J9311
Code system
HCPCS Level II
Full description
Injection, rituximab 10 mg and hyaluronidase
Policy activity for HCPCS J9311
CLV Intelligence is tracking 1 policy change that cite HCPCS J9311 most recently on 2026-09-12, drawn from 1 LCD/NCD coverage update. The changes span Oncology.
- LCD/NCD coverage update
- 1
Counts reflect the source documents CLV has matched to HCPCS J9311 to date; each links to the government publication that is authoritative. Monitored daily from CMS, the Federal Register, and Medicare Administrative Contractor publications.
Recent policy changes matched to J9311
Matched to this code by CLV analysis of each policy. The linked source document is authoritative.
Audit documentation
Building an audit file that includes HCPCS J9311?
The Tripwire Audit Pack exports 12 months of single-specialty policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
See audit packs — $349One-time purchase · not a subscription
Get alerts when policy changes affect J9311
Free weekly digest — no subscription required.
Get the free 90-day policy snapshot for your specialty
Free — no account required
See what CLV monitors for your specialty
Get a free 90-day sample snapshot — a PDF of every CMS and MAC policy change we tracked for your specialty and jurisdiction in the last quarter. Delivered instantly.
90-day windowPDF sample reportInstant download
By downloading, you agree to receive related policy update emails. You can unsubscribe at any time. Privacy policy